Oramed Pharmaceuticals (ORMP) Stock Price, Quote, News & History | Benzinga

Oramed Pharmaceuticals Inc (ORMP) Stock Price, Quote, News & History

ORMPNASDAQ

Trade with Public

Trade with Public

$5.02

-0.01-0.2%

At close: Aug 31, 5:00 PM EST

$5.10

0.081.59%

After Hours: 7:00 AM EST

OverviewNews Earnings Forecast Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$5.03

Close

$5.02

Volume / Avg.

242.85K / 300.75K

Day Range

$4.90 - $5.06

52 Wk Range

2.09 - 5.47

Market Cap

$212.15M

P/E Ratio

1.22

Dividend Yield

4.97%

Exchange

NASDAQ

RSI

64

Short Interest

2.91%

Days to Cover

5.85

Recent Oramed Pharmaceuticals Inc News

Top 4 Health Care Stocks That May Crash This Quarter

As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Avi Kapoor

Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Kidpik Corp. (NASDAQ: PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie 'World's Best'.

Lisa Levin

Dow Tumbles 250 Points; CarMax Posts Upbeat Results

U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday. Following the market opening Friday, the Dow traded down 0.74% to 33,695.28 while the NASDAQ fell 0.98% to 13,497.22. The S&P 500, also fell, dropping, 0.78% to 4,347.58.

Lisa Levin

Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.

Lisa Levin

Why Oramed Pharmaceuticals Shares Are Trading Higher Today

Oramed Pharmaceuticals Inc (NASDAQ: ORMP) shares are trading higher after its partner completed Phase 3 trials of oral insulin in type 2 diabetes in China

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-5.21M

Investing Cash Flow (TTM)

21.50M

Financing Cash Flow (TTM)

-16.68M

Free Cash Flow (TTM)

-7.14M

Capital Expenditure (TTM)

-1.93M

Net Change in Cash (TTM)

-387.00K

Valuation Metrics

Enterprise Value

$159.36M

PE Ratio (TTM)

1.22

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.66

Earnings Yield % (TTM)

82.11%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

2.10

Price / EBITDA (TTM)

2.79

Price / Free Cash Flow (TTM)

-

Book Value / Share

$7.63

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$15.25M

Debt to Equity

0.00

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$5.03

Close

$5.02

Volume / Avg.

242.85K / 300.75K

Day Range

$4.90 - $5.06

52 Wk Range

2.09 - 5.47

Market Cap

$212.15M

P/E Ratio

1.22

Dividend Yield

4.97%

Exchange

NASDAQ

RSI

64

Short Interest

2.91%

Days to Cover

5.85

About

Sector

Health Care

Industry

Pharmaceuticals

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Oramed Pharmaceuticals (ORMP) stock?

A

You can purchase shares of Oramed Pharmaceuticals (NASDAQ:ORMP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Oramed Pharmaceuticals (ORMP) competitors?

A

Other companies in Oramed Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Oramed Pharmaceuticals (ORMP) stock?

A

There is no analysis for Oramed Pharmaceuticals to provide a consensus price target.

Q

What is the current price for Oramed Pharmaceuticals (ORMP)?

A

The stock price for Oramed Pharmaceuticals (NASDAQ: ORMP) is $5.1 last updated August 31, 2026 at 7:00 AM EDT.

Q

Does Oramed Pharmaceuticals (ORMP) pay a dividend?

A

There are no upcoming dividends for Oramed Pharmaceuticals.

Q

When is Oramed Pharmaceuticals (NASDAQ:ORMP) reporting earnings?

A

Oramed Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Oramed Pharmaceuticals (ORMP) going to split?

A

There is no upcoming split for Oramed Pharmaceuticals.

Q

What sector and industry does Oramed Pharmaceuticals (ORMP) operate in?

A

Oramed Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.